Generic name: naldemedine tosylate 0.2mg
Dosage form: tablet
Medically reviewed by Drugs.com. Last updated on Jul 7, 2020.
- Alteration of analgesic dosing regimen prior to initiating SYMPROIC is not required.
- Patients receiving opioids for less than 4 weeks may be less responsive to SYMPROIC [see Clinical Studies (14)].
- Discontinue SYMPROIC if treatment with the opioid pain medication is also discontinued.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Frequently Asked Questions
More about Symproic (naldemedine)
- Side Effects
- During Pregnancy
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 19 Reviews
- Drug class: peripheral opioid receptor antagonists
- FDA Approval History